Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9252412rdf:typepubmed:Citationlld:pubmed
pubmed-article:9252412lifeskim:mentionsumls-concept:C0015127lld:lifeskim
pubmed-article:9252412lifeskim:mentionsumls-concept:C0006772lld:lifeskim
pubmed-article:9252412lifeskim:mentionsumls-concept:C0039063lld:lifeskim
pubmed-article:9252412lifeskim:mentionsumls-concept:C1314792lld:lifeskim
pubmed-article:9252412lifeskim:mentionsumls-concept:C1419206lld:lifeskim
pubmed-article:9252412lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:9252412pubmed:issue33lld:pubmed
pubmed-article:9252412pubmed:dateCreated1997-9-4lld:pubmed
pubmed-article:9252412pubmed:abstractTextThe GTPase Rab3A has been postulated to cycle on and off synaptic membranes during the course of neurotransmission. Moreover, a Rab guanine nucleotide dissociation inhibitor has been shown to cause Rab3A to dissociate from synaptic membranes in vitro. We demonstrate here that Ca2+/calmodulin also can cause Rab3A to dissociate from synaptic membranes in vitro. Like Rab guanine nucleotide dissociation inhibitor, it forms a 1:1 complex with Rab3A that requires both the lipidated C terminus of Rab3A and the presence of bound guanine nucleotide. In addition, a synthetic peptide corresponding to the Lys62-Arg85 sequence of Rab3A can prevent the dissociating effect of each protein and disrupt complexes between each protein and Rab3A. However, Ca2+/calmodulin's effect differs from that of Rab guanine nucleotide dissociation inhibitor not only in being Ca2+-dependent but also in having a less stringent requirement for GDP as opposed to GTP and in involving a less complete dissociation of Rab3A. The functional significance in vivo of Ca2+/calmodulin's effect remains to be determined; it may depend in part on the relative amounts of Ca2+/calmodulin and Rab guanine nucleotide dissociation inhibitor that are available for binding to Rab3A in individual, activated nerve termini.lld:pubmed
pubmed-article:9252412pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:languageenglld:pubmed
pubmed-article:9252412pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:citationSubsetIMlld:pubmed
pubmed-article:9252412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9252412pubmed:statusMEDLINElld:pubmed
pubmed-article:9252412pubmed:monthAuglld:pubmed
pubmed-article:9252412pubmed:issn0021-9258lld:pubmed
pubmed-article:9252412pubmed:authorpubmed-author:GlomsetJ AJAlld:pubmed
pubmed-article:9252412pubmed:authorpubmed-author:ParkJ BJBlld:pubmed
pubmed-article:9252412pubmed:authorpubmed-author:FarnsworthC...lld:pubmed
pubmed-article:9252412pubmed:issnTypePrintlld:pubmed
pubmed-article:9252412pubmed:day15lld:pubmed
pubmed-article:9252412pubmed:volume272lld:pubmed
pubmed-article:9252412pubmed:ownerNLMlld:pubmed
pubmed-article:9252412pubmed:authorsCompleteYlld:pubmed
pubmed-article:9252412pubmed:pagination20857-65lld:pubmed
pubmed-article:9252412pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:meshHeadingpubmed-meshheading:9252412-...lld:pubmed
pubmed-article:9252412pubmed:year1997lld:pubmed
pubmed-article:9252412pubmed:articleTitleCa2+/calmodulin causes Rab3A to dissociate from synaptic membranes.lld:pubmed
pubmed-article:9252412pubmed:affiliationHoward Hughes Medical Institute, Department of Medicine, University of Washington, Seattle, Washington 98195-7370, USA.lld:pubmed
pubmed-article:9252412pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9252412pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9252412pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252412lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9252412lld:pubmed